Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks ...

Phibro Animal Health just received a new price target, marking a fresh chapter in how the stock is being framed by analysts and investors. This update reflects a shift in expectations around the ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to ...

TEANECK, N.J.--(BUSINESS WIRE)--(NASDAQ: PAHC) The Food and Drug Administration (FDA), through its Center for Veterinary Medicine (CVM), has taken two actions regarding Mecadox ® (carbadox), a drug ...

JPMorgan upgraded Phibro Animal Health Corporation (NASDAQ:PAHC), citing strong execution following its $350 million acquisition of Zoetis' medicated feed additive and water-soluble product portfolio.

If you are wondering whether Phibro Animal Health's current share price lines up with its underlying worth, you are not alone. This article is built to help you think that through clearly. The stock ...

Animal health products manufacturer Phibro Animal Health (NASDAQ:PAHC) fell short of the markets revenue expectations in Q1 CY2026, with sales flat year on year at $347.8 million. On the other hand, ...

Phibro Animal Health Corp. entered into a definitive agreement to acquire Zoetis Inc.’s medicated feed additive product portfolio for $350 million. The New Jersey-based companies announced the ...